Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001477932-25-001847
Filing Date
2025-03-19
Accepted
2025-03-19 17:04:13
Documents
18
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A celz_10ka.htm   iXBRL 10-K/A 45838
2 CERTIFICATION celz_ex311.htm EX-31.1 3885
3 CERTIFICATION celz_ex312.htm EX-31.2 3882
  Complete submission text file 0001477932-25-001847.txt   259974

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA celz-20241231.xsd EX-101.SCH 6001
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE celz-20241231_lab.xml EX-101.LAB 22646
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE celz-20241231_cal.xml EX-101.CAL 898
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE celz-20241231_pre.xml EX-101.PRE 14648
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE celz-20241231_def.xml EX-101.DEF 2099
22 EXTRACTED XBRL INSTANCE DOCUMENT celz_10ka_htm.xml XML 6823
Mailing Address 211 E. OSBORN RD. PHOENIX AZ 85012
Business Address 211 E. OSBORN RD. PHOENIX AZ 85012 480-399-2822
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (Filer) CIK: 0001187953 (see all company filings)

EIN.: 870622284 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-41120 | Film No.: 25753590
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)